Surgery is not the first-line treatment option for patients with<unk> . It is usually reserved for patients with either massive protuberant proliferating<unk>  and lesions that are refractory to less invasive treatments.
Hemangioma surgery
Lymphangioma surgery
Cavernous angioma surgery
Schwannoma surgery
Neurofibroma surgery
Oligoastrocytoma surgery
Meningioma surgery
Retinoblastoma surgery